Clinical Trials Browser

Phase 3 × ruxolitinib × Lymphoid × Clear all

NCT04934670 2024-08-27

2002

Phase 3 Terminated

12 enrolled 12 charts

Pathologic Complete Response, Lymphoma, Follicular

NCT05663827 2024-03-05

Ruxolitinib as add-on Therapy in Steroid-refractory Graft-vs-host Disease

Phase 3 Completed

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma